Amgen Inc（AMGN）はNASDAQに上場しているHealthcare · Drug Manufacturers - Generalの企業です。 現在値 $412.84 (-1.13%)、時価総額 $179.05B、PER（株価収益率） 23.09、52週 安値・高値 $271.18 ~ $388.16。
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma;
Amgen Incの財務諸表、目標株価、機関投資家（13F）の保有状況、関連ニュースは BlackAll Trade でリアルタイムに確認できます。
最近の投稿 7件・強気 7・弱気 0・中立 0。
Amgen Incの現在の株価は$412.84 (-1.13%)です。BlackAll Trade でリアルタイムの株価とチャートを確認できます。
Amgen Incの時価総額は約$179.05Bです。PER は23.09です。
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, an